These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2870513)

  • 1. Benzodiazepine suppression of cortisol secretion: a measure of anxiolytic activity?
    Gram LF; Christensen P
    Pharmacopsychiatry; 1986 Jan; 19(1):19-22. PubMed ID: 2870513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels.
    Dimopoulou I; Tsagarakis S; Kouyialis AT; Roussou P; Assithianakis G; Christoforaki M; Ilias I; Sakas DE; Thalassinos N; Roussos C
    Crit Care Med; 2004 Feb; 32(2):404-8. PubMed ID: 14758155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
    Arborelius L; Skelton KH; Thrivikraman KV; Plotsky PM; Schulz DW; Owens MJ
    J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA; Akil H; Haskett RF; Watson SJ
    Biol Psychiatry; 1995 Mar; 37(6):355-63. PubMed ID: 7772643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of repeated human corticotropin-releasing hormone administration on dexamethasone-suppressed pituitary-adrenocortical activity in healthy subjects.
    Wiedemann K; Holsboer F
    Biol Psychiatry; 1997 Nov; 42(10):882-8. PubMed ID: 9359973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Afternoon cortisol levels before (spontaneous) and after suppression with dexamethasone or oxazepam in depressed patients.
    Christensen P; Gram LF; Kragh-Sørensen P; Nielsen S
    J Affect Disord; 1986; 10(3):171-6. PubMed ID: 2943769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing factor test in melancholic patients in depressed state versus recovery: a comparative study.
    Pintor L; Torres X; Navarro V; Martinez de Osaba MA; Matrai S; Gastó C
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1027-33. PubMed ID: 17433515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cortisol suppressing effect of dexamethasone and oxazepam in depressed patients; significance of spontaneous levels and interindividual distribution.
    Christensen P; Gram LF; Lolk A; Kragh-Sørensen P
    J Affect Disord; 1987; 13(3):273-8. PubMed ID: 2960720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implications.
    Kling MA; Gardner DL; Calogero AE; Coppola R; Trettau J; Kellner CH; Lefter L; Hart MJ; Cowdry RW; Post RM
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1548-64. PubMed ID: 8138967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists.
    Holsboer F; Ising M
    Eur J Pharmacol; 2008 Apr; 583(2-3):350-7. PubMed ID: 18272149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats.
    McElroy JF; Ward KA; Zeller KL; Jones KW; Gilligan PJ; He L; Lelas S
    Psychopharmacology (Berl); 2002 Dec; 165(1):86-92. PubMed ID: 12474122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression.
    Holsboer F; Von Bardeleben U; Gerken A; Stalla GK; Müller OA
    N Engl J Med; 1984 Oct; 311(17):1127. PubMed ID: 6090905
    [No Abstract]   [Full Text] [Related]  

  • 15. Afternoon plasma cortisol in relation to depression. A replication study.
    Christensen P; Lolk A; Pedersen OL; Nielsen S; Kragh-Sørensen P; Gram LF
    Acta Psychiatr Scand; 1988 Dec; 78(6):737-42. PubMed ID: 3223332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepine-induced sedation and cortisol suppression. A placebo-controlled comparison of oxazepam and nitrazepam in healthy male volunteers.
    Christensen P; Lolk A; Gram LF; Kragh-Sørensen P
    Psychopharmacology (Berl); 1992; 106(4):511-6. PubMed ID: 1349754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma ACTH and cortisol levels in benzodiazepine treated rats.
    Bruni G; Dal Pra P; Dotti MT; Segre G
    Pharmacol Res Commun; 1980 Feb; 12(2):163-75. PubMed ID: 6104336
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of plasma cortisol after oral administration of oxazepam in man.
    Gram LF; Christensen L; Kristensen CB; Kragh-Sorensen P
    Br J Clin Pharmacol; 1984 Feb; 17(2):176-8. PubMed ID: 6704288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diurnal rhythm of the corticotropin releasing hormone, adrenocorticotropin hormone and cortisol: implications for the therapeutic use of glucocorticoids].
    Djudjević G
    Srp Arh Celok Lek; 1987 Dec; 115(12):1181-200. PubMed ID: 2835826
    [No Abstract]   [Full Text] [Related]  

  • 20. Cortisol and treatment of depression: predictive value of spontaneous and suppressed cortisol levels and course of spontaneous plasma cortisol.
    Christensen P; Lolk A; Gram LF; Kragh-Sørensen P; Pedersen OL; Nielsen S
    Psychopharmacology (Berl); 1989; 97(4):471-5. PubMed ID: 2498943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.